Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 8,000 | |||
25 mg | 在庫あり | ¥ 13,000 | |||
50 mg | 在庫あり | ¥ 18,500 | |||
100 mg | 在庫あり | ¥ 24,000 | |||
200 mg | 在庫あり | ¥ 32,500 | |||
500 mg | 在庫あり | ¥ 54,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 9,000 |
説明 | Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease. |
ターゲット&IC50 | MAO-A:412 nM, MAO-B:4.43 nM |
別名 | AGN1135, TVP1012 |
分子量 | 171.24 |
分子式 | C12H13N |
CAS No. | 136236-51-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 23.4 mM
DMSO: 198.6 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rasagiline 136236-51-6 Apoptosis Metabolism Neuroscience BCL MAO Monoamine Oxidase inhibit TVP 1012 AGN1135 AGN-1135 (R)-AGN1135 Inhibitor TVP1012 AGN 1135 TVP-1012 inhibitor